First Australian Surgery with the Lateral Ti-LIFE Cage JULIET®Ti LL

Spineart is pleased to announce the first implantation of the Lateral Ti-LIFE cage JULIET®Ti LL in Australia.

Dr Ivan Bhaskar, neurosurgeon, successfully performed the procedure in St Vincent Hospital in Melbourne on November 20^th, 2020.

JULIET®Ti LL is a Lateral cage featuring Ti-LIFE Technology, a structure that mimics the geometry of trabecular bone and is designed to promote bone in-growth. JULIET®Ti LL features an overall reduction in material density, that optimizes medical imaging when making postoperative evaluations.

Related items
Date - Category	Title	Excerpt
11.11.2026 Corporativo	SPINEART SUPPORTED A CAMBODIA OUTREACH TRIP – CHILDREN’S SURGICAL CENTRE, PHNOM PENH	For the fifth consecutive year, Spineart is proud to support our ANZ distributor, Life Healthcare, in its charitable mission to Cambodia. Spineart provides all the implants and instruments required...
26.08.2026 Innovación	Spineart and eCential Robotics receive FDA 510(k) clearance for the PERLA® TL application for use with eCential® Op.n® navigation system for robotic procedures.	Geneva, Switzerland, August 26, 2026 – Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted...
11.08.2026 BAGUERA® C	Spineart Announces FDA Approval of BAGUERA® C Cervical Disc	Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from...

Related items

Date - Category

Illustration

Title

Excerpt

11.11.2026

Corporativo

SPINEART SUPPORTED A CAMBODIA OUTREACH TRIP – CHILDREN’S SURGICAL CENTRE, PHNOM PENH

For the fifth consecutive year, Spineart is proud to support our ANZ distributor, Life Healthcare, in its charitable mission to Cambodia. Spineart provides all the implants and instruments required...

26.08.2026

Innovación

Spineart and eCential Robotics receive FDA 510(k) clearance for the PERLA® TL application for use with eCential® Op.n® navigation system for robotic procedures.

Geneva, Switzerland, August 26, 2026 – Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted...

11.08.2026

BAGUERA® C

Spineart Announces FDA Approval of BAGUERA® C Cervical Disc

Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from...